Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) being developed for the treatment of multiple rare diseases including Classic Galactosemia, Sorbitol ...

A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 ...

Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a ...

Used in conjunction with the oral sonosensitizing agent 5-ALA, the sonodynamic therapy led to a median OS of 15.7 months in ...

Many people feel a mix of fear and curiosity with bees. But did you know some folks are turning to bee venom therapy for ...

STOCKHOLM, SWEDEN / ACCESSWIRE / November 27, 2024 / (STO:ALZCUR)(FRA:AC6) AB (publ) (FN STO:ALZCUR), a pharmaceutical ...

Arrowhead has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics for rare genetic disease ...

Last month, an Oak Bay teen spent six hours unconscious in Royal Jubilee Hospital after her drink was allegedly spiked at a ...

Researchers have developed a breakthrough system to deliver large therapeutic molecules into the brain, overcoming the challenges of the blood-brain barrier.

Rakovina Therapeutics will host a video conference call on Wednesday, November 27, 2024, at 10am PST to further discuss the data presented at the Society for Neuro-Oncology Annual Meeting and discuss ...

A Reuters report on Friday revealed that FDA researchers have found additional molecular evidence tying blockbuster asthma ...